Health ministry detailed that pregnant women should receive CoronaVac vaccine doses, an immunizer produced by the Chinese Laboratory Sinovac, and Pfizer vaccines.
In the case of those pregnant women who received AstraZeneca jab, they should seek a medical follow-up. Following the National Health Surveillance Agency (ANVISA) recommendations, 22 Brazilian states changed the vaccine doses for pregnant women.
The determination is valid until the completion of the analysis of a rare case of the death of a 35-year-old pregnant woman from hemorrhagic stroke, which may be related to the use of AstraZeneca.
Death is being investigated and, according to the federal government, it has not yet been proven that the inoculation has caused complication in pregnant woman.
According to Franciele Francinato, coordinator for the National Immunization Program, ‘some lab test details that are being investigated for conclusive closure of this case are still missing.’
Before this determination, health ministry decided on including all pregnant and postpartum women in priority group to receive the Covid-19 vaccine.
According to Jorge Kalil, head of the immunology laboratory of the Heart Institute of the Faculty of Medicine at the University of Sao Paulo and advisor to the National Vaccination Program, the relation of this case with AstraZeneca vaccine is not yet confirmed and adverse events are rare.